News in the Life Sciences Industry

BASEL, Switzerland, March 5, 2019 /PRNewswire/ -- Mundipharma EDO GmbH, part of the Mundipharma global network of independent associated companies, today announced that the first patient has been enrolled in the expansion stage of a Phase I/II clinical trial of tinostamustine in patients with... Read more ››

BURGWEDEL, Germany, March 5, 2019 /PRNewswire/ -- MYR Pharma announced today that the British Medicines and Healthcare products Regulatory Agency (MHRA) has issued the Promising Innovative Medicine (PIM) designation for MYR's lead compound Bulevirtide (Myrcludex). The designation is granted in... Read more ››

- PepsiCo's Former Vice Chairman and Chief Scientific Officer, Former President of Global R&D, Takeda Pharmaceuticals, to Lead Longevity Biotech -

- Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects

VIENNA, March 4, 2019 /PRNewswire/ -- Esaote announces the launch of the MyLab™X8 - the high-performance and versatile ultrasound platform to support hospitals and clinics facing today's challenges - at the European Congress of Radiology, ECR 2019 at booth number X5/510.

BRUSSELS, March 2, 2019 /CNW/ -- UCB, a global biopharmaceutical company, presented positive data from the Phase 2b BE ABLE extension study of bimekizumab in patients with moderate-to-severe chronic plaque psoriasis, which showed nearly all BE ABLE 1 responders completing 60 weeks of bimekizumab... Read more ››

WAYLAND, Massachusetts, March 2, 2019 /PRNewswire/ -- Syneron-Candela, a leading global medical aesthetic device company, announced today that it has rebranded the company to Candela and will be unveiling new corporate branding at the American Academy of Dermatology (AAD) Annual Meeting in Washington... Read more ››

SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ››

BRUSSELS, Feb. 28, 2019 /PRNewswire/ -- "We are confident for the future growth of UCB based on strong delivery in 2018, marking the fifth year of profitable growth in a row and a new blockbuster for UCB, Vimpat(®)," said Jean-Christophe Tellier, CEO UCB. "We are expecting Cimzia(®) to reach... Read more ››

VIENNA, Feb. 27, 2019 /PRNewswire/ -- Esaote announces the launch of the MyLab™X8 - the high-performance and versatile ultrasound platform to support hospitals and clinics facing today's challenges - at the European Congress of Radiology, ECR 2019 at booth number X5/510.

DUBLIN, Feb. 26, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter of 2018 and provided financial guidance for 2019.